Pulmonary Division, Heart Institute (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - São Paulo, Brazil.
Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.
PLoS One. 2020 Dec 3;15(12):e0242960. doi: 10.1371/journal.pone.0242960. eCollection 2020.
The pathophysiological mechanisms underlying chronic thromboembolic pulmonary hypertension (CTEPH) are still unclear. Endothelial cell (EC) remodeling is believed to contribute to this pulmonary disease triggered by thrombus and hemodynamic forces disbalance. Recently, we showed that HSP70 levels decrease by proatherogenic shear stress. Molecular chaperones play a major role in proteostasis in neurological, cancer and inflammatory/ infectious diseases. To shed light on microvascular responses in CTEPH, we characterized the expression of molecular chaperones and annexin A2, a component of the fibrinolytic system. There is no animal model that reproduces microvascular changes in CTEPH, and this fact led us to isolated endothelial cells from patients with CTEPH undergoing pulmonary endarterectomy (PEA). We exposed CTEPH-EC and control human pulmonary endothelial cells (HPAEC) to high- (15 dynes/cm2) or low- (5 dynes/cm2) shear stress. After high-magnitude shear stress HPAEC upregulated heat shock protein 70kDa (HSP70) and the HSP ER paralogs 78 and 94kDa glucose-regulated protein (GRP78 and 94), whereas CTEPH-ECs failed to exhibit this response. At static conditions, both HSP70 and HSP90 families in CTEPH-EC are decreased. Importantly, immunohistochemistry analysis showed that HSP70 expression was downregulated in vivo, and annexin A2 was upregulated. Interestingly, wound healing and angiogenesis assays revealed that HSP70 inhibition with VER-155008 further impaired CTEPH-EC migratory responses. These results implicate HSP70 as a novel master regulator of endothelial dysfunction in type 4 PH. Overall, we first show that global failure of HSP upregulation is a hallmark of CTEPH pathogenesis and propose HSP70 as a potential biomarker of this condition.
慢性血栓栓塞性肺动脉高压(CTEPH)的病理生理机制尚不清楚。内皮细胞(EC)重塑被认为是由血栓和血流动力失衡触发的这种肺部疾病的原因。最近,我们发现,前动脉粥样硬化剪切力会导致 HSP70 水平下降。分子伴侣在神经、癌症和炎症/感染性疾病的蛋白质平衡中发挥着重要作用。为了阐明 CTEPH 中的微血管反应,我们对分子伴侣和纤维蛋白溶解系统的组成部分 annexin A2 的表达进行了特征描述。目前还没有能够复制 CTEPH 中小血管变化的动物模型,这一事实促使我们从接受肺动脉内膜切除术(PEA)的 CTEPH 患者中分离出内皮细胞。我们将 CTEPH-EC 和对照人肺内皮细胞(HPAEC)暴露于高(15 dynes/cm2)或低(5 dynes/cm2)剪切力下。在高幅度剪切力下,HPAEC 上调热休克蛋白 70kDa(HSP70)和 HSP ER 同系物 78 和 94kDa 葡萄糖调节蛋白(GRP78 和 94),而 CTEPH-EC 未能表现出这种反应。在静态条件下,CTEPH-EC 中的 HSP70 和 HSP90 家族均减少。重要的是,免疫组织化学分析显示 HSP70 在体内表达下调,annexin A2 上调。有趣的是,伤口愈合和血管生成试验表明,用 VER-155008 抑制 HSP70 进一步损害了 CTEPH-EC 的迁移反应。这些结果表明 HSP70 是 4 型 PH 中内皮功能障碍的新型主调控因子。总的来说,我们首次表明 HSP 上调的整体失败是 CTEPH 发病机制的一个标志,并提出 HSP70 作为该疾病的潜在生物标志物。